Clinical trials
Dementia trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 9 |
| Recruiting | 6 |
| Unknown status | 6 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universitaire Ziekenhuizen KU Leuven | 4 |
| University Ghent | 4 |
| AstraZeneca | 3 |
| FORUM Pharmaceuticals Inc | 2 |
| Hasselt University | 2 |
| Janssen Research & Development, LLC | 2 |
| TauRx Therapeutics Ltd | 2 |
| prof. dr. Koen Van Laere | 2 |
| AbbVie | 1 |
| AviadoBio Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 34 |
| Alzheimer Disease | 22 |
| Cognitive Dysfunction | 7 |
| Neurodegenerative Diseases | 7 |
| Brain Diseases | 6 |
| Lewy Body Disease | 4 |
| Memory Disorders | 3 |
| Nervous System Diseases | 3 |
| Neurocognitive Disorders | 3 |
| Parkinson Disease | 3 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.